Biopharmaceutical
Oruka Therapeutics is a publicly traded biopharmaceutical company (Nasdaq: ORKA) developing novel biologics for the treatment of chronic skin diseases, with a primary focus on plaque psoriasis. The company's mission is to provide patients with chronic skin diseases the greatest possible freedom from their condition by achieving high rates of complete disease clearance with infrequent dosing of once or twice per year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases.
Industry
Biopharmaceutical
Company Size
51-200 employees
Remote Policy
Fully Remote
Beta · Sourced from candidate reports
Based on 2 candidate reports — more reports needed for aggregate stats
Ola's application at Oruka Therapeutics was rejected as the company decided to proceed with other candidates. He is actively seeking similar roles in life sciences and requested referrals to other opportunities.
The applicant received a rejection email from RemoteJobs.org informing them that the company decided to move forward with different candidates.
